Upcoming Events

Recent Publications

  • Zika virus NS5 protein antagonizes type I interferon production via blocking TBK1 activation.
  • In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection.
  • Exploring protein-protein interactions using the Site-Identification by Ligand Competitive Saturation (SILCS) methodology.
  • Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
  • A highly conductive, pliable and foldable Cu/cellulose paper electrode enabled by controlled deposition of copper nanoparticles.

IBBR News

  • University of Maryland iGEM team, co-advised by IBBR Fellow, Dr. Edward Eisenstein, brings home a gold medal for their innovative plastic waste bioremediation and degradation measurement project
  • IBBR welcomes middle school students for Frontiers in Science & Medicine Day
  • NIST Director and Standards Alumni Association honor former Associate Director of CARB
  • IBBR research discovery could be crucial to development of cross-species Ebola vaccines and treatments

Press Releases

  • IBBR investigator to lead $3.9M NIH-funded project to develop next generation HIV-1 immunotherapy agents
  • IBBR Receives $1.2M NIH Award to Develop 3D Modeling Tool That Could Lead to New Immunotherapies
  • IBBR Researcher, Dr. Alexander Andrianov, Receives Funding for Two Collaborations
  • Targeting HIV: Moving closer to a potential cure